
Ozempic maker Novo Nordisk’s shares plunge 18% on bleak 2026 forecast
Novo Nordisk shares plunged 18% after pre-releasing a weak 2026 outlook, citing US pricing pressure on Wegovy. CEO Mike Doustdar warned of near-term headwinds despite…

Novo Nordisk shares plunged 18% after pre-releasing a weak 2026 outlook, citing US pricing pressure on Wegovy. CEO Mike Doustdar warned of near-term headwinds despite…

Tamilnad Mercantile Bank posted double-digit growth in profit and net interest income for Q3, alongside improving asset quality and steady expansion in deposits, advances and…

Tube Investments of India reported strong Q3 earnings, with profit rising 18% year-on-year and margins expanding, alongside an interim dividend declaration and steady performance across…

Despite differing medium-term views, the Citizen MPC panel unanimously expects the RBI to keep the repo rate unchanged at the February 6 meeting, with Samiran…

Four major factors aided Lloyds Metals’ operating performance during the quarter, which also led to its margin expansion from the same quarter last year.

According to Emcure Pharma, profit growth was driven by strong traction across key therapies in India and sustained momentum in overseas markets.

Several companies, including NHPC, REC, JSW Steel, Prestige Estates and banks, are planning debt issuances through bonds and NCDs. The pipeline shows continued funding activity…

Seasonality benefits also reflected in the results for Emami as Winter accounts for 60% of the company’s sales.

RITES reported modest profit growth in Q3, while EBITDA rose sharply and margin expanded. The PSU also declared its third interim dividend, with shares trading…

Eureka Forbes’ exceptional loss of ₹40.44 crore was attributed to the estimated incremental impact on retiral benefits arising from the new labour codes, including provisions…